Cochrane Abstracts
Immediate‐release versus controlled‐release carbamazepine in the treatment of epilepsy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Immediate‐release Versus Controlled‐release Carbamazepine in the Treatment of Epilepsy." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434824/all/Immediate‐release_versus_controlled‐release_carbamazepine_in_the_treatment_of_epilepsy.
Immediate‐release versus controlled‐release carbamazepine in the treatment of epilepsy. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434824/all/Immediate‐release_versus_controlled‐release_carbamazepine_in_the_treatment_of_epilepsy. Accessed January 15, 2025.
Immediate‐release versus controlled‐release carbamazepine in the treatment of epilepsy. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434824/all/Immediate‐release_versus_controlled‐release_carbamazepine_in_the_treatment_of_epilepsy
Immediate‐release Versus Controlled‐release Carbamazepine in the Treatment of Epilepsy [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434824/all/Immediate‐release_versus_controlled‐release_carbamazepine_in_the_treatment_of_epilepsy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Immediate‐release versus controlled‐release carbamazepine in the treatment of epilepsy
ID - 434824
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434824/all/Immediate‐release_versus_controlled‐release_carbamazepine_in_the_treatment_of_epilepsy
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
